Boeing And 24 Stocks Moving Premarket

Gainers

• Qudian Inc. (NYSE:QD) rose 61.3% to $1.92 in pre-market trading after the company issued an update on its QD Food ready-to-cook meal business.
• AMTD Digital Inc. (NYSE:HKD) rose 40% to $22.70 in pre-market trading after gaining 108% on Friday. The company priced its IPO at $7 per share.
• ITHAX Acquisition Corp. (NASDAQ:ITHX) rose 31.4% to $18.39 in pre-market trading after jumping over 40% on Friday. ITHAX Acquisition’s shareholders approved business combination with Mondee.
• Intelligent Living Application Group Inc. (NASDAQ:ILAG) rose 25.8% to $2.83 in pre-market trading after declining 11% on Friday. The company reported closing of $20.24 million initial public offering.
• Vertical Aerospace Ltd. (NASDAQ:EVTL) rose 17% to $5.85 in pre-market trading. Vertical Aerospace shares jumped 72% on Friday after the company announced FLYINGGROUP has conditionally pre-ordered up to 50 VX4 aircrafts.
• LumiraDx Limited (NASDAQ:LMDX) rose 16.2% to $2.73 in pre-market trading after dropping around 10% on Friday. LumiraDx, last month, announced it achieved CE Mark for two new Fast Lab Solutions molecular tests, including Dual-Target SARS-CoV-2 STAR Complete and SARS-CoV-2 & Flu A/B RNA STAR Complete.
• SunLink Health Systems, Inc. (NASDAQ:SSY) rose 13% to $1.13 in pre-market trading. SunLink Health Systems reported a Q3 loss of $0.14 per share in May.
• Bitfarms Ltd. (NASDAQ:BITF) rose 12.8% to $1.32 in pre-market trading. The Paraguayan government has re-approved a cryptocurrency bill which will now regulate crypto mining and trading in the country.
• McEwen Mining Inc. (NYSE:MUX) rose 11.7% to $0.3980 in pre-market trading after declining 11% on Friday.
• Array Technologies, Inc. (NASDAQ:ARRY) rose 11.6% to $12.09 in pre-market trading.
• Franco-Nevada Corporation (NYSE:FNV) rose 11.5% to $142.00 in pre-market trading. Franco-Nevada today is expected to report its second quarter 2022 results on August 10, 2022.
• Second Sight Medical Products, Inc. (NASDAQ:EYES) rose 10.9% to $2.34 in pre-market trading.
• China Pharma Holdings, Inc. (NYSE:CPHI) rose 10.4% to $0.2270 in pre-market trading. China Pharma, last month, announced receipt of noncompliance notice from NYSE American.
• Esports Entertainment Group, Inc. (NASDAQ:GMBL) rose 10.3% to $0.44 in pre-market trading.
• Meten Holding Group Ltd. (NASDAQ:METX) rose 9.7% to $1.24 in pre-market trading.
• Offerpad Solutions Inc. (NYSE:OPAD) rose 9.6% to $2.40 in pre-market trading. Offerpad Solutions is expected to release Q2 financial results on Wednesday, August 3, 2022.
• Synthetic Biologics, Inc. (NYSE:SYN) rose 8.9% to $0.1775 in pre-market trading. Synthetic Biologics shares dipped 30% on Friday after the company announced a 1-for-10 reverse stock split.
• The Boeing Company (NYSE:BA) rose 2.7% to $151.75 in pre-market trading. The company said it expects demand for over 41,000 new airplanes by 2041 amid recovery in demand for international air travel. Boeing is reportedly nearing the end of regulatory hurdles for resuming deliveries of its 787 Dreamliner after a nearly two-year pause over some production defects.

Don’t forget to check out our premarket coverage here .

Losers

• United Maritime Corporation (NASDAQ:USEA) fell 32% to $4.13 in pre-market trading after jumping 176% on Friday. The company, last week, announced it will acquire a fleet of four Aframax petroleum tankers.
• AN2 Therapeutics, Inc. (NASDAQ:ANTX) shares fell 14.6% to $7.60 in pre-market trading after jumping around 15% on Friday.
• Aeterna Zentaris Inc. (NASDAQ:AEZS) fell 8.8% to $0.2170 in pre-market trading. Aeterna Zentaris announced shareholder approval of share consolidation.
• Healthcare Trust of America, Inc. (NYSE:HTA) fell 8% to $26.99 in pre-market trading. Healthcare Realty’s shareholders approved merger with Healthcare Trust Of America.
• Enochian Biosciences, Inc. (NASDAQ:ENOB) fell 7.7% to $2.01 in pre-market trading.
• Nymox Pharmaceutical Corporation (NASDAQ:NYMX) fell 7.2% to $0.2785 in pre-market trading after surging around 39% on Friday.
• Revelation Biosciences, Inc. (NASDAQ:REVB) fell 6.7% to $1.25 in pre-market trading. Revelation Biosciences recently announced data base lock for its Phase 1b CLEAR clinical study to evaluate the effect of intranasal REVTx-99b on nasal challenge allergen in participants with rhinitis to rye grass pollen.